# STOCKHOLM 1.0
#=GF ID   LMSTEN
#=GF AC   PF07988.16
#=GF DE   LMSTEN motif
#=GF PI   Wos2;
#=GF AU   Wood V;0000-0001-6330-7526
#=GF AU   Mistry J;0000-0003-2479-5322
#=GF AU   Bateman A;0000-0002-6982-4660
#=GF SE   Pfam-B_4851 (release 16.0)
#=GF GA   27.00 27.00;
#=GF TC   28.10 29.00;
#=GF NC   23.60 20.10;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch --cpu 4 -Z 75585367 -E 1000 HMM pfamseq
#=GF TP   Motif
#=GF RN   [1]
#=GF RM   10218098
#=GF RT   Myb and oncogenesis.
#=GF RA   Ganter B, Lipsick JS;
#=GF RL   Adv Cancer Res. 1999;76:21-60.
#=GF DR   INTERPRO; IPR012642;
#=GF DR   SO; 0001067; polypeptide_motif;
#=GF CC   This region of Myb proteins has previously been described as the
#=GF CC   transcriptional activation domain present in the vertebrate
#=GF CC   c-Myb and A-Myb, but neither vertebrate B-Myb proteins nor Myb
#=GF CC   proteins of invertebrates. Because vertebrate B-Myb (but neither
#=GF CC   A-Myb nor c-Myb) can partially complement Drosophila Myb null
#=GF CC   mutants, this region appears to have been a relatively recent
#=GF CC   insertion.
#=GF SQ   6
#=GS F6UHZ8_XENTR/240-286      AC F6UHZ8.4
#=GS H3ASH6_LATCH/238-285      AC H3ASH6.1
#=GS W5Q8B2_SHEEP/240-286      AC W5Q8B2.1
#=GS H0ZM23_TAEGU/242-288      AC H0ZM23.2
#=GS A0A8M1PBN3_DANRE/257-303  AC A0A8M1PBN3.1
#=GS G3PAJ8_GASAC/261-306      AC G3PAJ8.1
F6UHZ8_XENTR/240-286                 DSCIE..IQKSFSFIQQPFVDEDDPDKEKRIKELELLLMSAENEVRRKR
H3ASH6_LATCH/238-285                 QDCMETELQSNLAFVQQPFIE.DDPDKEQRIKELELLLMSAESEVRRKR
W5Q8B2_SHEEP/240-286                 GNCVE.HVQASSAFIQQPFVD.EDPDKEKKIKELELLLMSAENEVRRKR
H0ZM23_TAEGU/242-288                 GSCLE.HTPSSSNIVQQPFID.DDPDKEKKIKELELLLMSAENEIRRKQ
A0A8M1PBN3_DANRE/257-303             LNILN.FPQHGTAAIQRHYSD.EDPEKEKRVKEIEMLLMSTENELKGQQ
G3PAJ8_GASAC/261-306                 LNMLN.IPQHGAAAIQRHYGE.EDPEKEQRVKEIELLLMSTEDELRG.Q
#=GC seq_cons                        tsClE.hsQpusAhIQQPFlD.-DPDKEKRIKELELLLMSAENElRRKp
